SeekingAlpha · Sep 25, 2026
SBIO: Promising Pipelines, Insufficient Return Potential
SBIO should be treated as a speculative satellite holding; broader ETFs like XBI or IBB offer more balanced risk and maturity profiles. See why the fund is a Sell.
SB
AMEX · SBIO
ALPS Medical Breakthroughs ETF
Financial Services · Asset Management
$52.11
Up+$2.70 (+5.18%)
Updated Oct 20, 2026, 11:35 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 114.21M
- P/E ratio
- —
- Dividend yield
- 2.25%
- 52-week range
- $47.63 – $70.85
- Volume
- 20.07K
- Avg. volume
- 37.71K
Price performance · SBIO
SBIO price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 19, 2026
SBIO closed at $52.11 after 21 trading sessions, down 16.46% for the selected period.
- Last close
- $52.11
- Period change
- -16.46%
- Period low
- $50.12
- Period high
- $63.35
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | $50.82 | $52.41 | $50.8023 | $52.11 | 20.07K |
| Oct 16, 2026 | $52.22 | $52.22 | $49.93 | $50.12 | 20.71K |
| Oct 15, 2026 | $51.57 | $52.64 | $51.32 | $52.22 | 35.75K |
| Oct 14, 2026 | $51.18 | $52.15 | $50.98 | $51.20 | 33.69K |
| Oct 13, 2026 | $53.67 | $53.67 | $51.465 | $51.64 | 33.33K |
| Oct 12, 2026 | $54.88 | $54.90 | $53.74 | $53.85 | 22.7K |
| Oct 9, 2026 | $54.50 | $55.5141 | $54.365 | $55.04 | 33.64K |
| Oct 8, 2026 | $53.67 | $54.02 | $52.57 | $53.945 | 53.27K |
| Oct 7, 2026 | $53.80 | $54.96 | $53.80 | $54.13 | 49.17K |
| Oct 6, 2026 | $56.28 | $56.28 | $53.8901 | $54.38 | 93.2K |
| Oct 5, 2026 | $56.41 | $56.41 | $55.04 | $56.26 | 52.34K |
| Oct 2, 2026 | $57.37 | $57.37 | $55.925 | $56.15 | 59.46K |
| Oct 1, 2026 | $57.82 | $58.54 | $56.64 | $56.64 | 43.69K |
| Sep 30, 2026 | $58.42 | $59.02 | $57.85 | $58.30 | 21.98K |
| Sep 29, 2026 | $58.3502 | $58.48 | $57.28 | $57.94 | 26.79K |
| Sep 28, 2026 | $57.28 | $58.7299 | $56.79 | $57.93 | 29.74K |
| Sep 25, 2026 | $58.83 | $58.98 | $57.56 | $57.56 | 36.99K |
| Sep 24, 2026 | $59.55 | $59.55 | $57.7106 | $58.55 | 124.08K |
| Sep 23, 2026 | $63.19 | $63.19 | $59.36 | $59.85 | 57.01K |
| Sep 22, 2026 | $62.69 | $63.605 | $62.69 | $63.35 | 31.75K |
| Sep 21, 2026 | $62.96 | $62.96 | $61.935 | $62.38 | 35.77K |
Latest SBIO news
The latest Smart Investors Daily articles mentioning SBIO.
Stock researchCompany · Overview
Company
Market Activity
Research & News
SBIO research
Overview
Company profile and research snapshot.
Company profile
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Sep 22, 2026
SBIO: Big Pharma Needs What This Fund Owns
The ALPS Medical Breakthroughs ETF is a Buy, as its pullback offers a better entry into late-stage biotech. Click for more on the SBIO ETF.
Yahoo · Sep 8, 2026
Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)?
Sector ETF report for SBIO
Yahoo · Aug 27, 2026
SABIO BRINGS ITS CREATOR TV® FAST CHANNEL FEATURING CREATOR-LED PROGRAMMING TO VIZIO WATCHFREE+
Creator TV®, the creator-led streaming network and content studio owned and operated by Sabio Holdings (TSXV: SBIO) (OTCQB: SABOF), today announced that the Creator TV® FAST channel is now available on VIZIO's free-ad supported streaming service, WatchFree+.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
